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Abstract 
Background: As more countries progress towards malaria elimination, a better understanding of the most critical 
health system features for enabling and supporting malaria control and elimination is needed.
Methods: All available health systems data relevant for malaria control were collated from 23 online data reposito-
ries. Principal component analysis was used to create domain specific health system performance measures. Multiple 
regression model selection approaches were used to identify key health systems predictors of progress in malaria 
control in the 2000–2016 period among 105 countries. Additional analysis was performed within malaria burden 
groups.
Results: There was large heterogeneity in progress in malaria control in the 2000–2016 period. In univariate analysis, 
several health systems factors displayed a strong positive correlation with reductions in malaria burden between 2000 
and 2016. In multivariable models, delivery of routine services and hospital capacity were strongly predictive of reduc-
tions in malaria cases, especially in high burden countries. In low-burden countries approaching elimination, primary 
health center density appeared negatively associated with progress while hospital capacity was positively correlated 
with eliminating malaria.
Conclusions: The findings presented in this manuscript suggest that strengthening health systems can be an effec-
tive strategy for reducing malaria cases, especially in countries with high malaria burden. Potential returns appear 
particularly high in the area of service delivery.
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Background
To achieve a world free of malaria, health systems in 
malaria-endemic countries face a series of challenges: 
they need to identify populations at risk, cover at-risk 
populations with effective preventive interventions, 
accurately diagnose and report cases, and treat malaria 
patients with timely and high-quality care. Constraints to 
delivery of essential services not only cause inefficiencies, 
but can also hinder progress in malaria control [1–3]. 
Deficiencies in national health and surveillance systems 
likely contributed to the failure of the Global Malaria 
Eradication Programme 50  years ago [4]. As a result of 
lessons learned, ongoing elimination and eradication ini-
tiatives for other diseases have made a more purposeful 
effort to utilize and build upon existing service delivery 
mechanisms [5, 6], and the World Health Organization 
(WHO) Global Technical Strategy for Malaria now rec-
ommends that national strategic plans consider health 
systems readiness to expand malaria programmes [7]. 
The recent renewed enthusiasm for malaria eradication 
[8–10] has rekindled the dialogue and interest in whether 
present-day health systems are prepared for this bold 
endeavour [11].
Health system strength generally has not been 
a primary consideration in decisions to launch 
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disease eradication programmes, which have tradition-
ally focused on biological and technical factors, as well as 
costs and political will [12, 13]. Research and discourse 
on this topic has primarily focused on understanding 
the effects that vertical programmes have had on health 
systems [14, 15] and on outlining approaches to ensure 
that eradication activities confer maximum benefits to 
health systems while maintaining overall programmatic 
goals [13, 16]. In 2010, several studies were published on 
the technical and operational feasibility of malaria elimi-
nation. Most of these studies focused on strategies and 
needs for interrupting transmission, and on assessing 
countries’ ability to create effective national malaria pro-
grammes at scale [17–21]. The recent Lancet Commis-
sion on Malaria Eradication proposes an ambitious target 
of eradicating malaria by 2050. This report recognizes 
that a successful programme will need to strengthen 
health systems capacity by increasing human resources 
and developing management competency at the provin-
cial level, but highlights that historically malaria elimi-
nation has been achieved in many countries well before 
health systems have provided universal coverage [9].
To date, however, there has been limited quantitative 
analysis of the role of health systems in prior malaria con-
trol efforts, and for elimination programmes in particu-
lar. Measuring health systems performance is complex 
given the multi-dimensional nature of these systems and 
the variable importance of these dimensions in different 
contexts [22–24]. Over the last 15  years more data on 
health systems have become available at the global level, 
expanding the ability to characterize and compare health 
systems across countries. The main objective of this study 
was to utilize these datasets to empirically assess which 
aspects of health systems have been most predictive of 
progress towards malaria elimination from 2000 to 2016.
Methods
The conceptual approach for this study focused on iden-
tifying characteristics of health systems most predictive 
of progress in malaria control conditional on contextual 
factors, and is presented in Additional file  1: Analyti-
cal Framework. Contextual factors included the level of 
development of the country, initial malaria burden and 
broad resource availability to control for level of invest-
ments in the health sector. This framework was devel-
oped through review and feedback during meetings of 
the Strategic Advisory Group on malaria eradication in 
2018–2019.
Data sources
All available country-level information on health systems 
in the 2000–2016 period was extracted and combined in 
a new health system database. A total of 23 online data 
repositories related to malaria control and health sys-
tems were reviewed for relevant variables, including 
the World Development and Governance Indicators, 
the WHO Global Health Observatory, the World Bank 
Health Nutrition and Population database and coun-
try-level data provided through the Measure DHS pro-
gramme [25–32]. Additional file  2 gives a full list of all 
data sources for which variables were reviewed for inclu-
sion in the analysis.
Predictor variable identification and classification
A total of 83 health systems variables were grouped 
broadly into six categories following the building blocks 
of the WHO health system framework: health system 
financing, health service delivery, access to medicines, 
health system workforce and capacity, governance, and 
information systems [22]. Additionally, 35 macro-eco-
nomic, demographic and geographic indicators relevant 
for health systems and malaria control were reviewed for 
inclusion in the analysis as control variables. Variables 
covering less than 50% of the core sample of 105 malaria-
endemic countries were excluded from the analysis, and 
variables were also qualitatively reviewed for inclusion 
based on relevance to the analytical framework, as well 
as redundancy with other variables. Additional file 3 pro-
vides an overview of domain coverage for all variables 
reviewed for inclusion in the analysis, and Additional 
file  4 gives full definitions for all variables included in 
the analysis. Period averages for health systems variables 
were computed across the 2000–2016 period.
Outcome variables
In general, the outcome used for the regression analy-
sis was the relative reduction in malaria cases per 1000 
population (for Plasmodium falciparum and Plasmodium 
vivax combined) over the 2000–2016 period, obtained 
from the World Malaria Report [33]. Malaria incidence, 
rather than mortality, was used because it better aligned 
with the primary question of interest on progress towards 
elimination. In addition, many of the malaria mortal-
ity statistics published in the World Malaria Report are 
modelled by applying a static case fatality of 0.256%, thus 
containing limited information beyond the underlying 
case data [33]. In the absence of reliable mortality data, 
parasite prevalence reductions could have been a viable 
alternative in principle. However, this was not possible in 
practice because parasite prevalence estimates are mod-
elled using several health systems covariates as inputs, 
including health expenditure, antenatal care coverage, 
immunization coverage, and treatment-seeking behav-
iour [34, 35]. The primary outcome considered in this 
analysis was thus the reduction in the number of malaria 
cases per 1000 people over the 2000–2016 period. 
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Among low-burden countries (< 1 case per 1000 in 2000), 
a binary proxy for elimination of whether the country 
reached 0 cases by 2016 was also analysed, using unad-
justed surveillance data [33].
Preliminary (single variable) analysis
In a first step, all health systems variables (period aver-
ages) extracted for inclusion in the analysis were corre-
lated individually in unadjusted and adjusted regressions 
with absolute reductions in malaria cases between 2000 
and 2016 as the outcome. Adjusted regressions con-
trolled for initial level of development as measured by the 
Human Development Index (HDI), an indicator which 
includes income, education and life expectancy, and level 
of malaria burden (low, medium or high) in 2000 [32]. 
Regressions adjusted for HDI were also performed sepa-
rately within the three malaria-burden categories.
Data consolidation
Given that several variables were identified as proxies for 
the same health system aspects or concepts, health sys-
tem variables were consolidated into core domains for 
the main analysis. These domains were broadly defined 
using the WHO building block framework [22] except 
that health financing variables were considered as a con-
textual factor rather than a proxy of health system func-
tioning because they generally capture broad resource 
availability  which may affect all domains of health sys-
tems (Additional file  1). Using the final health systems 
dataset, any remaining missing data at the country level 
were imputed using multiple imputation chained equa-
tions. Additional file 5 shows descriptive statistics for all 
35 health systems variables in the original and imputed 
datasets. Principal component analysis was then used 
to consolidate the available data within each domain 
into core components of health systems. In cases where 
the first principal component accounted for the major-
ity of total domain variation observed (> 50%), only the 
first component was retained. If the first component 
explained less than 50%, additional sub-components were 
constructed until more than half of variation in each 
component was accounted for. Composite ‘health sys-
tems scores’ were generated by grouping countries into 
deciles for each component and summing deciles across 
domains.
Main analysis
First, health systems scores (summed scores and rank-
ings of countries by their scores) were plotted against 
progress in malaria control. In addition, the health sys-
tems features of countries performing at the top and bot-
tom of their respective burden categories were visually 
compared.
To identify the most predictive health system compo-
nents for successful malaria control conditional on ini-
tial malaria burden, initial HDI and average total health 
expenditure as percentage of GDP during 2000–2016, 
three empirical approaches were used: (1) standard 
regression models including all 7 health systems com-
ponents in the regression independent of the strength 
of their association with progress in malaria control; (2) 
backward stepwise selection (chosen among iterative 
search methods because it performed the best in terms 
of residual error and parsimony, as described further 
in Additional file  6); and, (3) a systematic combinatory 
approach which searched through every possible com-
bination of the 7 components (127 regressions in all) to 
minimize residual error. All models were estimated using 
linear regression with heterogeneity-robust standard 
errors [36, 37].
Given that the relative importance of specific health 
system factors likely varies across different stages of 
malaria control, separate models for countries with high 
initial incidence (≥ 300 cases per 1000 in 2000), moder-
ate initial incidence (1–299 cases per 1000 in 2000) and 
low initial incidence (< 1 case per 1000 in 2000) were 
fitted.
Results
As of 2000, malaria existed primarily in low and lower-
middle income countries. As Fig.  1 illustrates, 61 out 
of the 105 countries with at least one malaria case after 
20001 were classified as low-income, and 30 of these 
countries were classified as lower-middle income. Table 1 
Fig. 1 Initial burden of malaria by country income group. This figure 
shows the initial distribution of the 105 sample countries with respect 
to World Bank Income Category and initial malaria burden
1 These countries align with the ‘106 malaria-endemic countries’ detailed in 
the Lancet Commission on Malaria Eradication with the exception of Kazakh-
stan [9, 33].
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gives an overview of baseline and average malaria case 
burden and development level in the 2000–2016 period. 
Mean gross domestic product (GDP) per capita in this 
group increased from $4404 to $8454 during this period,2 
and countries on average reduced their case burden by 
60% (Table 1). 
Individual health systems variables and progress in malaria 
control
Out of 51 unique health system and financing variables 
identified, 26 variables showed statistically significant 
associations (p < 0.05) with reduction in malaria cases 
from 2000 to 2016 in univariate models. However, when 
models were adjusted for initial malaria burden and HDI 
in 2000, only five variables displayed statistically sig-
nificant associations with progress in malaria control: 
measles immunization coverage, tuberculosis treatment 
success rate, coverage of insecticide-treated nets (ITNs) 
among the high-risk population, children with fevers 
seeking care in the public sector, and malaria surveil-
lance reporting completeness. Additional file  7 summa-
rizes these results. When stratifying the adjusted models 
by initial burden of malaria, the strongest associations 
were in the highest burden group (> 300 cases per 1000) 
across four domains: overall health and malaria-specific 
financing, health service delivery, access to medicines, 
and health workforce and capacity (Additional file  8). 
Among high-burden countries only, the following health 
spending variables displayed positive correlations with 
reductions in malaria burden: percent of total health 
expenditure which is from foreign aid, external malaria 
financing per capita, and external malaria financing allo-
cated specifically for ITNs, treatment, diagnosis, and 
health system strengthening.
Principal component analysis
Table 2 shows the results of principal component analy-
ses within each domain of health systems, and Additional 
file  5 gives the full details and descriptive statistics for 
each of the variables included for each domain. A total 
of 7 principal health system components were identified, 
ranging from health service delivery to health informa-
tion systems.
Health systems scores
Total health system scores (the sum of the decile ranks 
in the 7 domains) ranged from 10 in the country with the 
weakest health system (Chad) to 69 in the country with 
the strongest health system (South Korea). This overall 
Table 1 Descriptive statistics for countries with at least one case of malaria after 2000 (N = 105)
a GDP per capita based on Purchasing Power Parity (in current international $)
b Human Development Index (HDI) is based on GDP, life expectancy and education
c HDI endline data are from 2015, the last year available in this dataset
Baseline (2000) Endline (2016)
Mean 95% CI Mean 95% CI
Malaria cases per 1000 131.6 (97.9, 165.3) 78.8 (55.1, 102.5)
GDPpc,  PPP
a $4402.5 ($3290.6, $5514.5) $8453.5 ($6724.0, $10,183.0)
HDIb 51.8 (49.0, 54.6) 60.0c (57.5, 62.5)
Table 2 Health systems components identified in principal component analysis (PCA)
No. Name of component No. of variables included % of domain 
variance 
explained
1 Health service delivery, routine services 6 60.1
2 Access to medicines 2 68.3
3 Health workforce 3 74.6
4 Health system capacity: basic health centers 2 91.6
5 Health system capacity: hospital capacity 2 56.1
6 Governance 8 64.8
7 Health information systems 2 74.2
2 Currency is expressed in current  international US Dollars, Purchasing 
Power Parity.
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score displayed a strong (and mostly linear) relationship 
with countries’ HDI in 2000 (Fig. 2).
Health systems scores were also strongly correlated 
with progress in malaria control between a health sys-
tems score of approximately 30 and 60, though the rela-
tionship was less strong towards the ends of the scale 
(Fig. 3).
When comparing the distribution of health systems 
scores of countries which reached zero cases of malaria 
versus those which did not (Fig. 4), there were no obvi-
ous differences for the low-burden category, which had 
median health systems scores of 51.5 and 49, respec-
tively. In the middle-burden group, differences in health 
systems scores were substantial: the median health sys-
tem score among countries reaching zero cases was 53, 
compared with 35 in the group which did not eliminate 
malaria. In the high-burden group, no countries reached 
zero cases by 2016, but countries on average scored more 
poorly on health systems compared with countries with 
lower initial burden.
When plotting change in malaria cases over time 
according to the ranking of the health system score of the 
county, large heterogeneity in progress can be observed 
across burden levels and health system scores (Fig. 5). In 
general, low-burden countries at baseline appeared to 
have relatively strong health systems while high-burden 
countries appeared to have lower ranking health systems. 
Within the high-burden category, the funnel shape of the 
arrows seems to indicate that more highly ranked health 
systems made greater progress in malaria control com-
pared with weaker systems. There were some remark-
able departures from the trend: five countries increased 
in malaria, including Rwanda which increased by 95% 
despite having a mid-ranked health system (Additional 
file  9). A literature search to better understand Rwan-
da’s increase in cases showed a potential gap in usage of 
effective interventions, e.g., due to pest infestation and 
perception about their control [38]; fortunately, Rwanda 
declined in cases from 2016 to 2017, a positive sign that 
this trend may be reversing [39]. In addition, there were 
substantial malaria reductions in countries with health 
systems ranked on the poorest end of the spectrum 
across all burden categories, including Bangladesh (BGD, 
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Fig. 4 Health systems score for countries which eliminated malaria 
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94%), South Sudan (SSD, 43%), and Democratic Republic 
of Congo (COD, 42%).
‘Best and worst performers’ analysis
When comparing health systems features of countries 
with major reductions in malaria incidence to those of 
countries with less progress, substantial differences were 
found.
Figure  6 shows the health systems scores of highest 
and lowest performers in terms of percentage reduction 
in the burden of malaria in the high initial burden group. 
Health systems scores for top performers (Guinea-Bis-
sau, Solomon Islands and Burundi) were overall higher 
in almost all domains than the health system scores for 
bottom performers (Niger, Mali and Guinea), though low 
performers appeared to have reasonably good basic facil-
ity coverage.
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Fig. 6 Health systems dimensions for highest and lowest performers for relative change in malaria cases, 2000–2016 among high burden countries 
(300+ cases per 1000 population)
Fig. 7 Health systems dimensions for highest and lowest performers for relative change in malaria cases, 2000–2016 among middle-burden 
countries (1–300 cases per 1000 population)
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Figure  7 compares health systems scores of highest 
and lowest performers among middle-burden coun-
tries in 2000. The three most successful countries in 
this category were Sri Lanka, Paraguay and Tajik-
istan: all three achieved a 100% reduction in malaria 
cases, and all had total health systems scores > 45. The 
low performers had a more complex story. Venezuela 
scored well on staffing, service delivery and data sys-
tems, but had a political and economic situation that 
deteriorated after 2012 leading to a severe malaria out-
break [40]. Rwanda scored reasonably well in terms 
of overall health system (score of 39), but regardless 
experienced a massive increase in malaria burden after 
2012  as discussed above. In comparison, Eritrea also 
experienced an increase in cases but scored poorly on 
health systems (score of 24).
Among low-burden countries, little difference was 
found in the health systems scores between the ‘high-
est’ and ‘lowest’ performers (Fig.  8); however, every 
country in this category made large progress towards 
malaria elimination. The weakest performer in this 
group was Panama which reduced cases by 44.3%. 
Additional file 9 provides progress estimates as well as 
health systems scores for all countries.
Combined health system regression results
Table  3 shows the main variable selection and regres-
sion results using outcomes of percent reduction in cases 
from 2000 to 2016 (‘malaria control’) and probability of 
reaching zero cases by 2016 among low-burden coun-
tries (‘malaria elimination’). Full model results including 
p-values are presented in Additional file 10. Column 1 of 
Table 3 shows results for a basic regression model includ-
ing all 7 components; columns 2 and 3 show results based 
on selected variables. The overall predictive power was 
weak for all malaria control models  (R2 = 0.17 to 0.20), 
and only moderately higher when restricted to coun-
tries approaching elimination in Columns 4–6  (R2 = 0.41 
to 0.45). For malaria control (columns 1–3), both back-
ward stepwise and grid search models showed a posi-
tive relationship between progress and hospital capacity 
(p = 0.041 for backwards; p = 0.014 for grid search); how-
ever, no health systems features showed a statistically 
significant relationship with malaria control in the model 
including all 7 components. For malaria elimination (col-
umns 4–6), greater primary health center density was 
associated with decreased probability of reaching zero 
cases (p = 0.027 for all 7 components model; p = 0.014 
for backward stepwise and grid search). Hospital capacity 
Fig. 8 Health systems dimensions for highest and lowest performers for relative change in malaria cases, 2000–2016 among low burden countries 
(< 1 case per 1000 population), excluding 14 countries which reached 0 cases
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was positively correlated with malaria elimination, but 
this result was only statistically significant in the back-
wards stepwise and grid search models (p = 0.007). In 
addition, elimination appeared slightly negatively asso-
ciated with good governance in all models, though this 
result was not statistically significant.
In the high burden category, health systems factors 
predicted progress in malaria control relatively well 
 (R2 = 0.71). Table  4 gives the model results stratified by 
initial malaria burden category. Among high-burden 
countries, health service delivery and hospital capac-
ity were strongly positively predictive of malaria pro-
gress: on average each standard deviation increase in 
ability to deliver services was associated with an addi-
tional 17 percentage point reduction malaria cases (95% 
CI: 12.2−22.2,  p < 0.001). Hospital density and capacity 
also showed a strong positive correlation with reduction 
in malaria cases (p < 0.001). Health information systems 
(including completeness of birth registration and malaria 
reporting) were negatively associated with malaria pro-
gress (p = 0.003), potentially due to some interdepend-
ence between completeness of malaria reporting and 
increased reporting of malaria cases. Among low- and 
middle-burden countries, health system factors had more 
limited power in predicting progress in malaria control 
 (R2 = 0.26 and 0.16, respectively), and no health systems 
Table 3 Regression model results (coefficients and  R-squared) for  malaria case reductions and  health system 
components, 2000–2016
All regressions adjust for HDI in 2000 and total health expenditure as percentage of GDP. Percent reduction models (columns I–III) also control for initial malaria 
burden category. Backward stepwise models exclude variables with p > 0.2 and include variables with p-values < 0.10. Grid search results reflect the model with lowest 
root mean squared error, among all models including up to 7 components
† This analysis was conducted only among countries in the low burden category (< 1 case per 1000 in 2000)
*: Variable is significant at p < 0.05; **: Variable is significant at p < 0.01
Health system component Percent reduction in cases per capita, 
2000–2016 (ß)
Reached 0 cases by 2016 (ß) (low-burden 
countries only)†
Model selection method All Backward stepwise Grid search All Backward stepwise Grid search
1 Health service delivery, routine services 4.2 5.1 4.9 − 0.05 Not selected Not selected
2 Access to medicines 4.3 Not selected Not selected − 0.13 Not selected Not selected
3 Health system workforce 0.6 Not selected Not selected 0.02 Not selected Not selected
4 Health system capacity: health centres 6.7 Not selected 6.6 − 0.10* − 0.10* − 0.10*
5 Health system capacity: hospitals 6.1 9.9* 6.9* 0.18 0.20** 0.20**
6 Governance 1.0 Not selected Not selected − 0.05 − 0.08 − 0.08
7 Health information systems − 0.5 Not selected Not selected 0.27 Not selected Not selected
R2 for model 0.20 0.17 0.20 0.45 0.41 0.41
Table 4 Backward stepwise regression model results (coefficients and R-squared) for malaria case reductions and health 
system components, 2000–2016, stratified by burden category
All regressions adjust for HDI in 2000 and total health expenditure as percentage of GDP. Backward stepwise models exclude variables with p > 0.2 and include 
variables with p-values < 0.1
*: Variable is significant at p < 0.05; **: Variable is significant at p < 0.01
a Initial burden category is defined as: Low = < 1 case per 1000 in 2000, Middle = 1–300 cases per 1000 in 2000, High = 300+ cases per 1000 in 2000
Health system component Percent reduction in cases per capita, 2000–2016 (ß) Reached 0 
cases by 2016 
(ß)
Initial burden  categorya Low Middle High Low
1 Health service delivery, routine services Not selected Not selected 17.2** Not selected
2 Access to medicines − 12.4 12.1 Not selected Not selected
3 Health system workforce Not selected Not selected Not selected Not selected
4 Health system capacity: health centres − 2.0 20.0 Not selected − 0.10*
5 Health system capacity: hospitals 5.6 Not selected 6.6** 0.20**
6 Governance Not selected Not selected − 4.5 − 0.08
7 Health information systems Not selected Not selected − 9.3** Not selected
R2 for backward stepwise model 0.26 0.16 0.70 0.41
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factors displayed statistically significant associations 
with progress in malaria control. In low-burden counties, 
health centre density appeared negatively associated with 
progress, though this result was not statistically signifi-
cant at standard cut-offs (p = 0.052).
Discussion
This study used all currently available quantitative data 
to identify the health systems factors most relevant for 
malaria control. While several factors were found to be 
associated with progress in malaria control, observed 
associations were highly heterogeneous overall, with 
no single factor or threshold predicting malaria control 
progress across all burden groups. In general, countries 
that were malaria endemic in 2000 and achieved zero 
malaria cases by 2016 had relatively high health systems 
scores (Fig.  5). However, when other contextual factors 
were controlled for, the predictive power of health sys-
tems factors was relatively limited (Table 3). The descrip-
tive analysis presented in this paper also makes it clear 
that rather remarkable progress has been made in several 
countries with very weak health systems. One of the pri-
mary reasons why this may be the case is the largely ver-
tical nature of many national malaria programmes. Prior 
research shows that the interventions responsible for 
the greatest malaria reductions during this period have 
been vector control programmes (foremost distribution 
of ITNs, as well as indoor residual spraying campaigns) 
[41], which are often delivered through vertical processes 
by organizations external to national health systems [42, 
43]. These heterogeneous results highlight that context-
specific health system strengthening approaches are 
needed for malaria control and elimination.
Investment in health systems is already considered an 
important aspect of malaria control programmes [44]. 
In its eighth round of funding, the Global Fund to Fight 
AIDS, Tuberculosis and Malaria, which provides 96% of 
external malaria funding, allocated 37% (US$362 million) 
of its overall funding towards health systems strengthen-
ing, of which US$139 million went towards general health 
systems support and the remaining went to disease-spe-
cific system strengthening [45]. The vast majority (82%) 
of overall health systems funding went towards three 
building blocks: service delivery, human resources and 
medicines [45]. Among low-burden countries approach-
ing elimination, the large majority of external financing 
in countries goes towards vertical interventions includ-
ing treatment, diagnosis and vector control, although 
the portion allocated for health system strengthening is 
growing [46].
High-burden countries, which generally tend to have 
weaker health systems, may see the largest benefits from 
health systems strengthening interventions. Amid recent 
increases in cases between 2015 and 2017 especially 
among the highest burden countries [9], revitalization of 
malaria control approaches are needed in these countries. 
After restricting the adjusted analysis to high burden 
countries, health systems displayed strong correlations 
with progress in malaria control. These findings are 
inconsistent with a mostly theoretical literature which 
suggests that research and investments in health systems 
are likely to have a larger impact in middle-burden coun-
tries rather than in low- or high-burden countries [47]. 
Specifically, among high-burden countries service deliv-
ery and hospital-level infrastructure appear to be most 
predictive of malaria control progress (Table  4). This 
appears well aligned with the Global Fund’s current focus 
on routine service delivery, including investments in 
quality improvement as well as infrastructure [44].
In low- and middle-burden countries, health systems 
factors overall have much lower predictive power for pro-
gress in malaria control and moderately more for elimi-
nation. In low-burden countries approaching elimination, 
greater density of lower level health facilities appeared 
negatively correlated with elimination; however, these 
results were heavily influenced by China, Mexico and 
South Korea which all had high coverage of health facili-
ties but did not eliminate malaria and had large reduc-
tions in malaria burden (> 99, 94 and 87%, respectively); 
this may be an indication of more highly developed 
health systems having stronger surveillance systems and 
therefore being less likely to have reported zero cases in 
2016. In addition, hospital capacity (including density of 
hospitals and hospital beds) appeared to play a role, likely 
related to former Soviet countries (Azerbaijan, Tajikistan, 
Kyrgyzstan) which traditionally had hospital-centred sys-
tems and achieved zero indigenous cases of malaria dur-
ing this time frame. Finally, all models for low-burden 
countries displayed a negative (but not significant) rela-
tionship between governance and malaria elimination, 
potentially driven by some successful malaria campaigns 
in countries which scored poorly on governance due to 
political instability and lack of freedom of expression 
(e.g., Syria, Iraq, Algeria). This apparent negative relation-
ship with governance is consistent with a detailed case 
review of nine malaria elimination programmes which 
found that countries which had clearer lines of account-
ability and responsibilities (e.g., in Turkey and Turkmeni-
stan) had more successful campaigns [48].
The analysis presented was limited by the quality of 
data on malaria and health systems in several ways. First, 
the malaria incidence data analysed depend on local sur-
veillance capacity, and likely do not capture all cases in 
many countries. This should not affect the main results 
since the primary outcome analysed was changes over 
time within countries. Second, the more than 20 publicly 
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available health systems data sources continue to have 
insufficient coverage for a time-series analysis, which 
means that period averages have to be used instead of 
year-specific health system measures. Beyond the inher-
ent challenges in quantitatively disentangling the com-
plex relationship between health systems and other social 
and ecological factors important for malaria control, the 
static nature of the data meant that it was not possible to 
draw causal inference. There is a critical need for better 
and more consistent data on health systems at the coun-
try level which inform on the strength and process of the 
health system [23, 24]. Several health systems variables 
that are potentially important for malaria control, such 
as medicines availability at primary health care centres 
were entirely excluded due to lack of data coverage. The 
Service Provision Assessment (SPA) and Service Avail-
ability and Readiness Assessment (SARA) surveys pre-
sent opportunities to better understand country health 
systems as well as the impact of these factors on malaria 
control, but are currently only available for 8 and 13 
countries, respectively [49, 50]. Higher quality data 
across countries will allow for additional, more nuanced 
assessments of health systems readiness for disease con-
trol initiatives as well as better monitoring of their health 
systems impact.
Conclusions
The results presented in this paper highlight the large 
heterogeneity in the progress made in malaria control 
during the period 2000 to 2016, as well as the large het-
erogeneity in countries’ current health systems infra-
structure. While many factors appear relevant for malaria 
control, the results presented here show that there is no 
single health systems factor or threshold that dominates 
other factors in countries’ ability to move towards elimi-
nation. Additional health systems strengthening support 
will likely have the largest impact in high-burden coun-
tries, especially in the domain of service delivery.
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